http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103381188-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103381188-B |
| titleOfInvention | The application of Houttuynoid B in preparation treatment atherosclerosis medicine |
| abstract | The present invention relates to the application of Houttuynoid B in preparation treatment atherosclerosis medicine.Houttuynoid B is by adjusting blood lipid, protection endotheliocyte and play antiatherogenic effect.With antiatherogenic drugs on atherosclerotic prepared by Houttuynoid B, there is good curative effect, can be used for the atherosclerosis of anti-human or animal.The Houttuynoid B that the present invention relates to belongs to first public preparing the purposes in Antiatherosclerosis medicine, because framework types belongs to brand-new framework types, and it is unexpectedly strong for atherosclerotic inhibit activities, there is not the possibility being provided any enlightenment by other compounds, possess outstanding substantive distinguishing features, for atherosclerosis, obviously there is significant progress simultaneously. |
| priorityDate | 2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.